{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/121323"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/121323","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"US pharmaceutical firms’ international redeployment strategies, entry modes, and performance outcomes","abstract":"Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2025-08-01","abstract_html":"Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2025-08-01","abstract_has_math":false,"creators":["Xu, Mingrui"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Business Administration","degree_department":null,"school":null,"contributors":["Mahoney, Joseph T.","Yao, Fiona Kun","Sakhartov, Arkadiy","Schijven, Mario"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-08","date_published":"2023-08","updated_at":"2026-07-22T22:24:57Z","subjects":["Redeployability","Resource Redeployment","Entry Mode","Expatriate Staffing","Pharmaceutical Industry"],"languages":["en","eng"],"rights":["Copyright 2023 Mingrui Xu"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2142/121323","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Mahoney, Joseph T.","Yao, Fiona Kun","Sakhartov, Arkadiy","Schijven, Mario"]},{"key":"dc:creator","label":"Author","values":["Xu, Mingrui"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-08","2023-06-30"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Business Administration"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Redeployability","Resource Redeployment","Entry Mode","Expatriate Staffing","Pharmaceutical Industry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en","eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2023 Mingrui Xu"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/2142/121323"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2025-08-01","The student, Mingrui Xu, accepted the attached license on 2023-06-28 at 14:41.","The student, Mingrui Xu, submitted this Dissertation for approval on 2023-06-28 at 14:58.","This Dissertation was approved for publication on 2023-06-30 at 15:41.","DSpace SAF Submission Ingestion Package generated from Vireo submission #19475 on 2023-12-04 at 17:18:08","This dissertation provides three empirical studies investigating multinational enterprises’ (MNEs) entry mode decisions, performance outcomes of the sequential moves of divestitures and subsequent greenfield investments, and expatriate staffing, respectively. From the redeployability perspective, all three empirical studies explore how MNEs’ sequential decision-making may help modify their resource base to improve performance and secure competitive advantage. With the context of US pharmaceutical firms’ global investments, this dissertation seeks to connect the redeployability perspective with international business (IB) phenomena and thus provide more empirical evidence for this value-creation mechanism through which firms free up and redeploy resources across countries. In addition, this dissertation examines potential boundary conditions for the redeployability perspective in IB research."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["US pharmaceutical firms’ international redeployment strategies, entry modes, and performance outcomes"]}]}],"canonical_facts":{"dc:contributor":["Mahoney, Joseph T.","Yao, Fiona Kun","Sakhartov, Arkadiy","Schijven, Mario"],"dc:creator":["Xu, Mingrui"],"dc:date":["2023-08","2023-06-30"],"dc:description":["Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2025-08-01","The student, Mingrui Xu, accepted the attached license on 2023-06-28 at 14:41.","The student, Mingrui Xu, submitted this Dissertation for approval on 2023-06-28 at 14:58.","This Dissertation was approved for publication on 2023-06-30 at 15:41.","DSpace SAF Submission Ingestion Package generated from Vireo submission #19475 on 2023-12-04 at 17:18:08","This dissertation provides three empirical studies investigating multinational enterprises’ (MNEs) entry mode decisions, performance outcomes of the sequential moves of divestitures and subsequent greenfield investments, and expatriate staffing, respectively. From the redeployability perspective, all three empirical studies explore how MNEs’ sequential decision-making may help modify their resource base to improve performance and secure competitive advantage. With the context of US pharmaceutical firms’ global investments, this dissertation seeks to connect the redeployability perspective with international business (IB) phenomena and thus provide more empirical evidence for this value-creation mechanism through which firms free up and redeploy resources across countries. In addition, this dissertation examines potential boundary conditions for the redeployability perspective in IB research."],"dc:format":["application/pdf"],"dc:identifier":["https://hdl.handle.net/2142/121323"],"dc:language":["en","eng"],"dc:rights":["Copyright 2023 Mingrui Xu"],"dc:subject":["Redeployability","Resource Redeployment","Entry Mode","Expatriate Staffing","Pharmaceutical Industry"],"dc:title":["US pharmaceutical firms’ international redeployment strategies, entry modes, and performance outcomes"],"dc:type":["text"],"thesis:degree_discipline":["Business Administration"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:57Z"}